Delivery Order SPE2DU25D2017-SPE2DU26FAD53
- Not listed
- The Defense Logistics Agency awarded a $73,894 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 8, 2026, with an ultimate completion date of the same day. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999. The parent company, Cencora,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,028.55 on November 24, 2025, under a Defense Logistics Agency (DLA) contract. This firm fixed-price, competitively awarded delivery order with an ultimate completion date of November 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,181.76 by the Defense Logistics Agency's Medical Supply Chain on June 28, 2025, with an ultimate completion date of June 30, 2025. This firm fixed-price delivery order is a non-set-aside contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 potential value through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,666.14 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,791.30 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,355.40 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,523.20 on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside contract utilizes firm fixed pricing and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency program. The delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., which...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract valued at $4,448.96 from the Defense Logistics Agency's Medical Supply Chain division on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- SPE2DU25D2017Indefinite Delivery Contract
- SPE2DU25D2017-SPE2DU26FAD53Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,838.33 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant IDC valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's contract portfolio with the Defense Logistics Agency encompasses diverse pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains such as oncology, diabetes management, pain management, and neurology. The company serves critical federal healthcare customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents a routine execution under the established IDC framework, consistent with AmerisourceBergen's role as a key pharmaceutical prime vendor supporting military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/7/26 |